Cara Therapeutics Inc. sell StockNews.com
Start price
17.02.24
/
50%
€0.54
Target price
17.02.25
-
Performance (%)
-25.51%
End price
18.02.25
-
Summary
This prediction is currently being closed. The prediction for Cara Therapeutics Inc. shows a convincing performance of -25.51%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.218% | 1.751% | 2.663% |
| iShares Nasdaq 100 | -2.352% | 0.218% | 32.486% |
| iShares Nikkei 225® | -3.105% | 2.933% | 56.978% |
| iShares S&P 500 | -0.497% | 1.985% | 24.470% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten